Molecular testing in the management of cardiac transplant recipients: Initial clinical experience

被引:72
作者
Starling, Randall C.
Pham, Michael
Valantine, Hannah
Miller, Leslie
Eisen, Howard
Rodriguez, E. Rene
Taylor, David O.
Yamani, Mohamad H.
Kobashigawa, Jon
McCurry, Kenneth
Marboe, Charles
Mehra, Mandeep R.
Zuckerman, Andreas
Deng, Mario C.
机构
[1] Columbia Univ, Div Cardiol, Dept Med, Coll Phys & Surg, New York, NY 10032 USA
[2] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA
[3] Stanford Univ, Dept Cardiovasc Med, Stanford, CA 94305 USA
[4] Fairview Univ, Div Cardiovasc, Minneapolis, MN USA
[5] Drexel Univ, Div Cardiol, Philadelphia, PA 19104 USA
[6] Univ Calif Los Angeles, Div Clin Fac Med, Los Angeles, CA USA
[7] Univ Pittsburgh, Pittsburgh, PA USA
[8] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[9] Univ Maryland, Div Cardiol, Baltimore, MD 21201 USA
[10] Med Univ Vienna, Dept Surg, Vienna, Austria
关键词
D O I
10.1016/j.healun.2006.10.002
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:1389 / 1395
页数:7
相关论文
共 18 条
[1]
Gene expression profiling of cardiac allograft recipients with mild acute cellular rejection [J].
Bernstein, D. ;
Mital, S. ;
Addonizio, L. ;
Hunt, S. ;
Deng, M. C. ;
Baron, H. ;
Murali, S. ;
Tayama, D. Y. ;
Klingler, T. M. ;
Wohlgemulh, J. G. ;
Webber, S. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02) :S65-S65
[2]
Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation [J].
Brunner-La Rocca, HP ;
Kiowski, W .
TRANSPLANTATION, 1998, 65 (04) :533-538
[3]
Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience [J].
Chin, C ;
Naftel, DC ;
Singh, TP ;
Blume, ED ;
Luikart, H ;
Bernstein, D ;
Gamberg, P ;
Kirklin, JK ;
Morrow, WR .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (02) :178-185
[4]
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling [J].
Deng, MC ;
Eisen, HJ ;
Mehra, MR ;
Billingham, M ;
Marboe, CC ;
Berry, G ;
Kobashigawa, J ;
Johnson, FL ;
Starling, RC ;
Murali, S ;
Pauly, DF ;
Baron, H ;
Wohlgemuth, JG ;
Woodward, RN ;
Klingler, TM ;
Walther, D ;
Lal, PG ;
Rosenberg, S ;
Hunt, S .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) :150-160
[5]
Deng MC, 2004, AM J TRANSPLANT, V4, P455
[6]
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients [J].
Eisen, HJ ;
Tuzcu, EM ;
Dorent, R ;
Kobashigawa, J ;
Mancini, D ;
Valantine-von Kaeppler, HA ;
Starling, RC ;
Sorensen, K ;
Hummel, M ;
Lind, JM ;
Abeywickrama, KH ;
Bernhardt, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :847-858
[7]
Daclizumab to prevent rejection after cardiac transplantation [J].
Hershberger, RE ;
Starling, RC ;
Eisen, HJ ;
Bergh, CH ;
Kormos, RL ;
Love, RB ;
Van Bakel, A ;
Gordon, RD ;
Popat, R ;
Cockey, L ;
Mamelok, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2705-2713
[8]
Insights into host responses against pathogens from transcriptional profiling [J].
Jenner, RG ;
Young, RA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (04) :281-294
[9]
KIRKLIN JK, 1992, CIRCULATION, V86, P236
[10]
Increased molecular testing scores associated with agreement among cardiac pathologists for the diagnosis of ISHLT 3A and higher rejection [J].
Marboe, C. C. ;
Deng, M. C. ;
Berry, G. ;
Billingham, M. ;
Eisen, H. J. ;
Pauly, D. ;
Baron, H. ;
Klingler, T. ;
Lal, P. ;
Mahmood, I. ;
Wohlgemuth, J. ;
Starling, R. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02) :S105-S106